These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32931481)

  • 1. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.
    Kong X; Zeng D; Wu X; Wang B; Yang S; Song Q; Zhu Y; Salas M; Qin H; Nasri U; Haas KM; Riggs AD; Nakamura R; Martin PJ; Huang A; Zeng D
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32931481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrafollicular CD4
    Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
    Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells, murine chronic graft-versus-host disease and autoimmunity.
    Eisenberg RA; Via CS
    J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.
    Young JS; Wu T; Chen Y; Zhao D; Liu H; Yi T; Johnston H; Racine J; Li X; Wang A; Todorov I; Zeng D
    J Immunol; 2012 Jul; 189(1):222-33. PubMed ID: 22649197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
    Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
    J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.
    Kong X; Wu X; Wang B; Zeng D; Cassady K; Nasri U; Zheng M; Wu A; Qin H; Tsai W; Salhotra A; Nakamura R; Martin PJ; Zeng D
    Blood; 2022 Dec; 140(25):2740-2753. PubMed ID: 36084473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.
    Nguyen V; Luzina I; Rus H; Tegla C; Chen C; Rus V
    J Immunol; 2012 Jul; 189(2):1081-93. PubMed ID: 22723520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity.
    Rus V; Nguyen V; Puliaev R; Puliaeva I; Zernetkina V; Luzina I; Papadimitriou JC; Via CS
    J Immunol; 2007 Mar; 178(6):3962-72. PubMed ID: 17339497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 Deficiency Ameliorates Chronic Graft-
    Martínez-Blanco Á; Domínguez-Pantoja M; Botía-Sánchez M; Pérez-Cabrera S; Bello-Iglesias N; Carrillo-Rodríguez P; Martin-Morales N; Lario-Simón A; Pérez-Sánchez-Cañete MM; Montosa-Hidalgo L; Guerrero-Fernández S; Longobardo-Polanco VM; Redondo-Sánchez S; Cornet-Gomez A; Torres-Sáez M; Fernández-Ibáñez A; Terrón-Camero L; Andrés-León E; O'Valle F; Merino R; Zubiaur M; Sancho J
    Front Immunol; 2021; 12():713697. PubMed ID: 34504495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-Y Aggravates Murine Chronic Graft-
    Wan L; Jin Z; Hu B; Lv K; Lei L; Liu Y; Song Y; Zhu Y; Gong H; Xu M; Du Y; Xu Y; Liu H; Wu D; Liu Y
    Front Immunol; 2020; 11():559740. PubMed ID: 33329519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
    Asano T; Meguri Y; Yoshioka T; Kishi Y; Iwamoto M; Nakamura M; Sando Y; Yagita H; Koreth J; Kim HT; Alyea EP; Armand P; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Maeda Y; Tanimoto M; Ritz J; Matsuoka KI
    Blood; 2017 Apr; 129(15):2186-2197. PubMed ID: 28151427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.
    Deng R; Cassady K; Li X; Yao S; Zhang M; Racine J; Lin J; Chen L; Zeng D
    J Immunol; 2015 Jan; 194(2):560-74. PubMed ID: 25488990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
    Wu Y; Schutt S; Paz K; Zhang M; Flynn RP; Bastian D; Sofi MH; Nguyen H; Dai M; Liu C; Chang YJ; Blazar BR; Yu XZ
    Blood; 2018 Apr; 131(17):1974-1986. PubMed ID: 29530952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target antigens determine graft-versus-host disease phenotype.
    Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
    J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.
    Choudhury A; Cohen PL; Eisenberg RA
    Clin Immunol; 2010 Jul; 136(1):105-15. PubMed ID: 20381429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.